GlaxoSmithKline says HPV vaccine worked in study

Courtesy Newsvine - business  Tue, 07/07/2009 - 11:37

Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.


 

Related items

FDA approves Glaxo's cervical cancer vaccine
British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women.

Glaxo AIDS Drug Has 'Spectacular' Results in Study
GlaxoSmithKline Plc's experimental AIDS drug reduced the virus as much as 500-fold without the signs of resistance linked to treatments from Merck & Co. and Gilead Sciences Inc., a study...

Struggling biotech Epix Pharmaceuticals goes bust
Epix, a struggling biotechnology firm working with British drug maker GlaxoSmithKline PLC to develop an Alzheimer's disease drug, says it is winding down its operations and selling off assets...

NNTN4930A Original OEM Motorola Nextel i830 Lithium...

HP 02 Black Twin Pack Ink Cartridge with Vivera Ink
Double up on HP 02 black cartridges - which feature patented, dye-based ink for superior photos - and you'll save 8% over the cost of purchasing two individually.


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com